Press Releases - Oramed Pharmaceuticals

Oramed Appoints Dr. Anne Peters to its Scientific Advisory Board

June 1, 2022

Oramed to Present at H.C. Wainwright Global Investment Conference

May 18, 2022

Oramed Completes Patient Enrollment in Pivotal Phase 3 Oral Insulin Study ORA-D-013-1

May 3, 2022

Oramed Granted NASH Patent in Europe

April 5, 2022

Oramed Appoints Yadin Rozov to its Board of Directors

April 4, 2022

Oramed’s Diabetes Market Survey Shows Strong Interest for ORMD-0801 Oral Insulin Candidate Among Physicians

March 29, 2022

Oramed to Host Key Opinion Leader Webinar on Need for Oral Insulin in Type 2 Diabetes

March 22, 2022